InvestSMART

Memphasys Limited (ASX: MEM) - Announcements

- Current share price for MEM : $0.004

ASX company news and announcements for Memphasys Limited (MEM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Memphasys Limited (MEM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Memphasys Limited (MEM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Memphasys Limited (MEM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 Consolidation/Split - MEM 26 Oct 2026 4:21PM $0.005 $0.004 fallen by 20%
$12 Notice of Annual General Meeting/Proxy Form 26 Oct 2026 4:16PM $0.005 $0.004 fallen by 20%
$12 Notification regarding unquoted securities - MEM 14 Oct 2026 11:25AM $0.005 $0.004 fallen by 20%
$12 Quarterly Activities/Appendix 4C Cash Flow Report 13 Oct 2026 9:14AM $0.005 $0.004 fallen by 20%
$12 Initial Director's Interest Notice 6 Oct 2026 8:44AM $0.005 $0.004 fallen by 20%
$12 Proposed issue of securities - MEM 29 Sep 2026 9:54AM $0.005 $0.004 fallen by 20%
$12 Memphasys receives A$3.5 million from Peters Investments 29 Sep 2026 9:44AM $0.005 $0.004 fallen by 20%
$12 Potential Expedited FDA Pathway to US IVF Market 25 Sep 2026 9:35AM $0.005 $0.004 fallen by 20%
$12 Change of Director's Interest Notice 21 Sep 2026 12:12PM $0.006 $0.004 fallen by 33.33%
$12 Notification regarding unquoted securities - MEM 18 Sep 2026 4:27PM $0.006 $0.004 fallen by 33.33%
$12 Notification regarding unquoted securities - MEM 18 Sep 2026 4:22PM $0.006 $0.004 fallen by 33.33%
$12 Application for quotation of securities - MEM 18 Sep 2026 4:18PM $0.006 $0.004 fallen by 33.33%
$12 Memphasys Secures European Felix Agreement 18 Sep 2026 8:45AM $0.006 $0.004 fallen by 33.33%
$12 Memphasys Investor Webinar Presentation - September 2026 8 Sep 2026 9:01AM $0.007 $0.004 fallen by 38.46%
$12 Investor Webinar Invite 4 Sep 2026 11:41AM $0.006 $0.004 fallen by 33.33%
$12 Felix Registration Achieved in Turkey, Sales Commence 3 Sep 2026 9:32AM $0.005 $0.004 fallen by 20%
$12 Notification of cessation of securities - MEM 2 Sep 2026 9:30AM $0.005 $0.004 fallen by 20%
$12 EUR526,500 Nordic Agreement Expands Felix European Footprint 1 Sep 2026 9:29AM $0.005 $0.004 fallen by 20%
$12 Appendix 4G and Corporate Governance Statement 31 Aug 2026 6:47PM $0.005 $0.004 fallen by 20%
$12 Appendix 4E and 2026 Annual Report 31 Aug 2026 6:43PM $0.005 $0.004 fallen by 20%
$12 Felix Early Thai FDA Approval, Commercial Launch Accelerates 28 Aug 2026 8:40AM $0.006 $0.004 fallen by 27.27%
$12 Results of General Meeting 21 Aug 2026 5:37PM $0.006 $0.004 fallen by 33.33%
$12 Felix Registration Achieved in Vietnam and Cartridge Order 20 Aug 2026 8:48AM $0.006 $0.004 fallen by 33.33%
$12 Pivotal Felix Study Receives First Scientific Presentation 10 Aug 2026 9:28AM $0.006 $0.004 fallen by 33.33%
$12 European Commercial Roll-out continues with Poland Agreement 5 Aug 2026 8:44AM $0.007 $0.004 fallen by 42.86%

1 - 25 of 647 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.